Examining the Usage of Dopamine Blockers in OCD Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00496925 |
Recruitment Status
:
Completed
First Posted
: July 6, 2007
Last Update Posted
: February 2, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
We examine the usage of Dopamine blockers in OCD patients. We want to examine their frequency of usage, compare the course of the disease between those who receive and those who do not receive Dopamine blockers, and efficacy of the treatment.
The study will be done in two stages: 1. Collecting information the usage of Dopamine blockers from 150 OCD patients' files. 2. interviewing 60-70 patients to see the difference those who receive and those who do not receive Dopamine blockers in their current severity of disease.
Condition or disease |
---|
Obsessive Compulsive Disorder |
Study Type : | Observational |
Actual Enrollment : | 63 participants |
Observational Model: | Cohort |
Time Perspective: | Cross-Sectional |
Official Title: | Examining the Usage of Dopamine Blockers in OCD Patients |
Study Start Date : | November 2007 |
Actual Primary Completion Date : | July 2009 |
Actual Study Completion Date : | July 2009 |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Patients over 18 years of age
- DSM-IV diagnosis of OCD
- Ability to understand patient information sheet, and consent to participate
Exclusion Criteria:
- Current or past Psychotic or Bipolar disorder

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00496925
Israel | |
Chaim Sheba Medical Center | |
Ramat-Gan, Israel, 52621 |
Principal Investigator: | Joseph Zohar, MD | Chaim Sheba Medical Center |
Responsible Party: | Prof. Joseph Zohar, Chaim Sheba Medical Center |
ClinicalTrials.gov Identifier: | NCT00496925 History of Changes |
Other Study ID Numbers: |
SHEBA- 07-4651-JZ-CTIL |
First Posted: | July 6, 2007 Key Record Dates |
Last Update Posted: | February 2, 2010 |
Last Verified: | January 2010 |
Additional relevant MeSH terms:
Compulsive Personality Disorder Obsessive-Compulsive Disorder Personality Disorders Mental Disorders Anxiety Disorders Dopamine Dopamine Antagonists Cardiotonic Agents |
Sympathomimetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Dopamine Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Protective Agents |